Back to search
FDAFDA · Food and drugs·Recall number Z-2372-2012

Omnilife Science Apex Knee System Modular Tibia Augment, Size 3 x 4mm Ref: KC-54030. The Apex Knee System is intended for use as a primary or revision total knee replacement.

Published September 19, 2012 · Recall initiated: August 9, 2012

Summary

FDA records medical device Class II recall Z-2372-2012, published September 19, 2012 and initiated August 9, 2012. Recalling firm: Omni Life Science; Status: Terminated; Reported quantity: 310 units; Lot: Lot Numbers: 8363, 8715, 8864, 8876, 8982, 9007, 9013, 9123, 9168, 10317. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The Apex Knee System Modular Tibia Augment may breach the inner and outer sterile pouches, compromising the sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Omni Life Science
Distributor
Worldwide Distribution-USA (nationwide including the states of CO, NY, OK, PA, UT, VA, and WI, and the countries of Spain and the Netherlands.
Lot
Lot Numbers: 8363, 8715, 8864, 8876, 8982, 9007, 9013, 9123, 9168, 10317
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Omnilife Science Apex Knee System Modular Tibia Augment, Size 3 x 4mm Ref: KC-54030. The Apex Knee System is intended for use as a primary or revision total knee replacement. recalled?

Yes. FDA published recall Z-2372-2012 on September 19, 2012. Reported hazard: The Apex Knee System Modular Tibia Augment may breach the inner and outer sterile pouches, compromising the sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit